Prot #M12-901: A Phase 1b Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Relapsed or Refractory Multiple Myeloma Subjects who are Receiving Bortezomib and Dexamethasone as their Standard Therapy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/25/14 → 9/25/17

Funding

  • AbbVie Inc. (Prot #M12-901)